🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/06/2008 23,80 24,30 23,50 23,70 -2,47% 3,36% 6.640
23/06/2008 24,20 24,70 23,60 24,30 -3,19% 4,55% 7.850
20/06/2008 25,00 25,40 23,90 25,10 +1,62% 6,00% 17.350
19/06/2008 23,50 24,70 23,50 24,70 +5,11% 5,11% 9.660
18/06/2008 23,50 23,90 23,10 23,50 +0,86% 3,40% 4.100
17/06/2008 22,50 23,90 22,50 23,30 +4,02% 6,22% 5.740
16/06/2008 22,90 23,00 21,80 22,40 -2,61% 5,24% 5.440
13/06/2008 22,80 23,00 21,60 23,00 +2,22% 6,14% 5.140
12/06/2008 21,00 22,70 21,00 22,50 +5,63% 8,10% 7.910
11/06/2008 22,10 22,90 21,00 21,30 -3,62% 8,60% 16.820
10/06/2008 22,30 23,00 21,90 22,10 -1,78% 4,93% 13.370
09/06/2008 23,00 24,40 22,30 22,50 -2,17% 9,13% 12.400
06/06/2008 23,70 24,00 22,90 23,00 -3,77% 4,64% 8.820
05/06/2008 23,80 24,50 23,68 23,90 +0,84% 3,45% 12.530
04/06/2008 23,30 24,70 23,10 23,70 +1,72% 6,87% 9.010
03/06/2008 23,80 25,00 23,00 23,30 -1,69% 8,40% 13.260
02/06/2008 24,80 25,70 23,50 23,70 -4,05% 8,87% 36.640
30/05/2008 25,60 26,00 24,50 24,70 -3,14% 5,86% 15.930
29/05/2008 25,40 26,50 25,10 25,50 +0,00% 5,51% 15.480
28/05/2008 26,20 26,30 25,10 25,50 -2,30% 4,58% 8.620
27/05/2008 27,00 27,00 25,20 26,10 +5,24% 6,67% 21.660
23/05/2008 26,90 26,90 24,70 24,80 -0,80% 8,18% 14.410
22/05/2008 24,20 25,00 23,30 25,00 +3,31% 7,02% 14.600
21/05/2008 25,10 25,40 23,50 24,20 -2,42% 7,57% 14.410
20/05/2008 25,50 25,90 24,20 24,80 +1,22% 6,67% 16.650
19/05/2008 24,50 25,00 24,00 24,50 -1,21% 4,08% 21.840
16/05/2008 26,70 27,20 24,70 24,80 -2,36% 9,36% 28.730
15/05/2008 26,80 26,80 25,20 25,40 -1,93% 5,97% 15.360
14/05/2008 26,00 26,70 25,70 25,90 +0,00% 3,85% 7.900
13/05/2008 26,90 26,90 25,80 25,90 -0,38% 4,09% 15.270